Marathon Capital Management’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.55M Sell
79,407
-4,164
-5% -$311K 1.14% 28
2026
Q2
$6.01M Buy
83,571
+47,735
+133% +$4.49M 1.22% 26
2026
Q1
$4.24M Buy
35,836
+686
+2% +$84.8K 0.95% 35
2025
Q4
$4.42M Buy
+35,150
New +$4.58M 0.95% 35
2021
Q4
– Sell
-1,865
Closed -$363K – 227
2021
Q3
$363K Buy
+1,865
New +$376K 0.08% 134

Other funds holding ZTS

Marathon Capital Management's ZTS Position: Q3 2026 in Review

Marathon Capital Management reduced its Zoetis (ZTS) stake by 5% in Q3 2026, selling an estimated $311K and leaving 79,407 shares worth $5.55M. The position accounts for 1.14% of the portfolio, ranked #28.

Marathon Capital Management first reported a position in ZTS in Q3 2021 and has held it in 5 quarters since. The position peaked at $6.01M in Q2 2026. 724 funds tracked by Wall St. Rank hold ZTS as of Q3 2026.

  • Marathon Capital Management held 79,407 shares of Zoetis worth $5.55M as of Q3 2026.
  • Marathon Capital Management sold 4,164 Zoetis shares in Q3 2026, an estimated $311K.
  • Zoetis made up 1.14% of Marathon Capital Management's portfolio in Q3 2026, its #28 holding.
  • Marathon Capital Management first reported a position in Zoetis in Q3 2021 and has held it in 5 quarters since.
  • Marathon Capital Management's Zoetis position peaked at $6.01M in Q2 2026.
  • 724 funds tracked by Wall St. Rank held Zoetis as of Q3 2026.

Based on Marathon Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.